Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
LXRX — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree LXRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

LXRX — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the Lexicon Pharmaceuticals Insider Buying occurred are:

Allied Gaming and Entertainment Insider Buying
Northfield Bancorp Inc (DE) Insider Buying
Valley National Bancorp (NJ) Insider Buying
Selective Insurance Group Insider Buying
Guggenheim Taxable Municipal Bond and Investment Grade Debt Trust Insider Buying
Cato Insider Buying
Intel Insider Buying
Dorchester Minerals LP Insider Buying
Sigma Additive Solutions Insider Buying
Treasure Global Insider Buying

Lexicon Pharmaceuticals insider buying image
The table below summarizes the most recent Lexicon Pharmaceuticals insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Lexicon Pharmaceuticals insider buys are important for investors to follow.
DateInsiderPriceAmount
11-13-2023
Insider Buy		 Philippe Amouyal
Director		 $1.01
CAGR » 		$201,520.00
200,000 shares
6-26-2023
Insider Buy		 Lonnel Coats
Chief Executive Officer		 $2.34
CAGR » 		$46,742.00
20,000 shares
6-22-2023
Insider Buy		 Lonnel Coats
Chief Executive Officer		 $2.31
CAGR » 		$92,400.00
40,000 shares
6-20-2023
Insider Buy		 Jeffrey L. Wade
President and CFO		 $2.33
CAGR » 		$28,000.00
12,000 shares
11-16-2023
Insider Buy		 Lonnel Coats
Chief Executive Officer		 $1.05
CAGR » 		$94,797.00
90,000 shares
11-10-2023
Insider Buy		 Lonnel Coats
Chief Executive Officer		 $1.01
CAGR » 		$10,100.00
10,000 shares
10-12-2023
Insider Buy		 Raymond Debbane
Director		 $1.10
CAGR » 		$1,103,956.59
1,000,000 shares
9-14-2023
Insider Buy		 Jeffrey L. Wade
President and CFO		 $1.38
CAGR » 		$13,800.00
10,000 shares
8-4-2023
Insider Buy		 Wendy McDermott
VP, Human Resources		 $1.84
CAGR » 		$11,040.00
6,000 shares
6-29-2023
Insider Buy		 Lonnel Coats
Chief Executive Officer		 $2.16
CAGR » 		$21,600.00
10,000 shares
6-23-2023
Insider Buy		 Wendy McDermott
VP, Human Resources		 $2.43
CAGR » 		$24,300.00
10,000 shares
6-5-2023
Insider Buy		 International S.C.A. Artal
Director and >10% Owner		 $2.60
CAGR » 		$72,215,130.00
27,775,050 shares
8-5-2022
Insider Buy		 Invus US Partners LLC
Director and >10% Owner		 $2.50
CAGR » 		$368,475.00
147,390 shares
8-5-2022
Insider Buy		 International S.C.A. Artal
Director and >10% Owner		 $2.50
CAGR » 		$6,065,175.00
2,426,070 shares
8-1-2022
Insider Buy		 International S.C.A. Artal
Director and >10% Owner		 $2.50
CAGR » 		$40,434,500.00
16,173,800 shares
8-1-2022
Insider Buy		 Invus US Partners LLC
Director and >10% Owner		 $2.50
CAGR » 		$2,456,500.00
982,600 shares
8-1-2022
Insider Buy		 Raymond Debbane
Director		 $2.50
CAGR » 		$2,456,500.00
982,600 shares
12-16-2020
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $3.20
CAGR » 		$35,000,000.00
10,937,500 shares
12-16-2020
Insider Buy		 International S.C.A. Artal
Director and >10% Owner		 $3.20
CAGR » 		$35,000,000.00
10,937,500 shares
9-13-2019
Insider Buy		 Christopher J. Sobecki
Director		 $2.41
CAGR » 		$238,750.09
99,249 shares
8-2-2019
Insider Buy		 James F. Tessmer
VP, Finance & Accounting		 $1.14
CAGR » 		$11,400.00
10,000 shares
9-18-2019
Insider Buy		 Alexander A. Santini
EVP and CCO		 $3.36
CAGR » 		$15,115.00
4,500 shares
9-18-2019
Insider Buy		 Lonnel Coats
President and CEO		 $3.10
CAGR » 		$155,000.00
50,000 shares
9-17-2019
Insider Buy		 Lonnel Coats
President and CEO		 $3.13
CAGR » 		$156,403.06
50,000 shares
9-16-2019
Insider Buy		 Christopher J. Sobecki
Director		 $2.55
CAGR » 		$63,717.58
25,000 shares
9-13-2019
Insider Buy		 Raymond Debbane
Director		 $2.40
CAGR » 		$474,759.80
197,473 shares
9-16-2019
Insider Buy		 Raymond Debbane
Director		 $2.69
CAGR » 		$277,591.21
103,042 shares
8-19-2019
Insider Buy		 Lonnel Coats
President and CEO		 $1.35
CAGR » 		$54,028.72
40,000 shares
8-2-2019
Insider Buy		 Sam L. Barker
Director		 $1.18
CAGR » 		$28,200.00
24,000 shares
6-28-2018
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $12.51
CAGR » 		$2,287,376.72
182,838 shares
6-25-2018
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $12.99
CAGR » 		$3,295,173.13
253,725 shares
6-21-2018
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $13.29
CAGR » 		$970,045.19
72,973 shares
6-18-2018
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $12.98
CAGR » 		$594,398.91
45,784 shares
6-12-2018
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $12.80
CAGR » 		$3,014,123.06
235,396 shares
6-4-2018
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $12.01
CAGR » 		$5,002,666.67
416,481 shares
6-7-2018
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $12.58
CAGR » 		$4,095,065.19
325,639 shares
5-30-2018
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $9.94
CAGR » 		$4,306,418.18
433,378 shares
5-23-2018
Insider Buy		 Alexander A. Santini
EVP and CCO		 $9.78
CAGR » 		$7,286.10
745 shares
11-17-2017
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $10.11
CAGR » 		$1,826,895.85
180,727 shares
11-15-2017
Insider Buy		 Lonnel Coats
President and CEO		 $9.91
CAGR » 		$99,100.00
10,000 shares
11-14-2017
Insider Buy		 Invus Public Equities, L.P.
Director and >10% Owner		 $9.64
CAGR » 		$5,554,165.52
575,946 shares
11-14-2017
Insider Buy		 Jeffrey L. Wade
EVP, Corp Adm Affairs and CFO		 $9.48
CAGR » 		$18,961.80
2,000 shares
9-15-2017
Insider Buy		 Sam L. Barker
Director		 $12.50
CAGR » 		$12,500.00
1,000 shares
9-15-2017
Insider Buy		 Lonnel Coats
President and CEO		 $12.54
CAGR » 		$376,336.70
30,000 shares
12-12-2014
Insider Buy		 C.V. Invus
Director and >10% Owner		 $0.88
CAGR » 		$132,030.00
150,000 shares
12-10-2014
Insider Buy		 C.V. Invus
Director and >10% Owner		 $0.90
CAGR » 		$285,348.86
315,896 shares
11-26-2014
Insider Buy		 International S.C.A. Artal
Director and >10% Owner		 $1.00
CAGR » 		$149,999,999.66
149,253,731 shares
10-23-2012
Insider Buy		 International S.C.A. Artal
Director and >10% Owner		 $2.25
CAGR » 		$6,750,000.00
3,000,000 shares
10-23-2012
Insider Buy		 CV Invus,
Director and >10% Owner		 $2.25
CAGR » 		$6,750,000.00
3,000,000 shares
3-19-2010
Insider Buy		 Ulys, LLC
>10% Owner		 $1.15
CAGR » 		$108,410,736.90
94,270,206 shares
10-22-2009
Insider Buy		 Sam L. Barker
Director		 $1.56
CAGR » 		$29,672.00
19,000 shares
10-15-2009
Insider Buy		 Ulys, LLC
>10% Owner		 $1.50
CAGR » 		$23,182,717.50
15,455,145 shares

Also See: Institutional Holders of LXRX
Also See: SEC filings

LXRX Performance Since Insider Purchase
Below we present the annualized performance delivered by Lexicon Pharmaceuticals stock since 11-13-2023 (the date of the most recent insider purchase). The performance of the investment from the time Lexicon Pharmaceuticals insider buying occurred is the ultimate test of whether insiders were right about LXRX being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 11/14/2023
End date: 04/24/2024
Start price/share: $1.12
End price/share: $1.60
Dividends collected/share: $0.00
Total return: 42.86%
Annualized Gain: 97.16%
Starting investment: $10,000.00
Ending investment: $14,286.00
Years: 0.44

Lexicon Pharmaceuticals Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Lexicon Pharmaceuticals insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding LXRX

Lexicon Pharmaceuticals Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.